Berry Genomics Co.,Ltd reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 549.42 million compared to CNY 667.33 million a year ago. Revenue was CNY 560.7 million compared to CNY 680.3 million a year ago.

Net loss was CNY 95.11 million compared to CNY 18.61 million a year ago. Basic loss per share from continuing operations was CNY 0.269 compared to CNY 0.06 a year ago. Diluted loss per share from continuing operations was CNY 0.269 compared to CNY 0.06 a year ago.